Clinical Trial Update: Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing early chemotherapy based on CA 125 levels versus delayed chemotherapy in recurrent ovarian epithelial, fallopian tube, or primary perito…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Medical Research Council | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 3 | Status: COMPLETED